Profile
CDIO VRTX REGN VRNA ARGX ALNY
Company Name Cardio Diagnostics Holdings, Inc. Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Verona Pharma plc argenx SE Alnylam Pharmaceuticals, Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $6.99M $115.36B $77.44B $72.68B $52.08B $51.68B
Employees 0.01K 6.10K 15.16K 0.21K 1.60K 2.23K
CEO Meeshanthini V. Dogan Reshma Kewalramani Leonard S. Schleifer David S. Zaccardelli Timothy Van Hauwermeiren Yvonne L. Greenstreet
Ratings
CDIO VRTX REGN VRNA ARGX ALNY
Quant Rating Score 2 4 4 1 4 3
Quant Rating Sell Buy Buy Strong Sell Buy Neutral
Trading
CDIO VRTX REGN VRNA ARGX ALNY
Last Close $2.99 $434.02 $704.31 $106.91 $929.61 $460.54
High 52 $5.35 $513.76 $788 $106.91 $929.61 $491.09
Low 52 $0.16 $366.54 $482.92 $37.86 $532.27 $224.58
Price vs. 52 Week High -44.11 % -15.52 % -10.62 % 0 % 0 % -6.22 %
Price vs. 52 Week Low 1768.75 % 18.41 % 45.84 % 182.38 % 74.65 % 105.07 %
Total Return
CDIO VRTX REGN VRNA ARGX ALNY
1 Month Return -30.22 % 4.13 % 21.84 % 0 % 10.19 % -4.39 %
3 Month Return -19.62 % 11.32 % 22.74 % 1.06 % 40.57 % 0.8 %
6 Month Return -22.14 % -1.06 % 18.51 % 49.92 % 64.35 % 61.42 %
9 Month Return 391.45 % -6.08 % 3.57 % 66.4 % 45.48 % 84.22 %
YTD Return 226.06 % 7.78 % -1.13 % 130.21 % 51.16 % 95.72 %
1 Year Return 1050.44 % -3.12 % -5.41 % 180.68 % 61.8 % 96.59 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
CDIO VRTX REGN VRNA ARGX ALNY
Dividend Yield Percentage (TTM) - - 0.47 % - - -
Dividend Paid and Capex Coverage Ration (TTM) -35.02 % 9.76 % 4.25 % -147.93 % 65.28 % 5.97 %
Dividend Per Share (TTM) - - 3.52 % - - -
Payout Ratio (TTM) - - 6.06 % - - -
Growth
CDIO VRTX REGN VRNA ARGX ALNY
Asset Growth 137.89 % 14.15 % 53.91 %
Gross Profit Growth 104.45 % 12.5 % -
Revenue Growth 104.45 % 8.27 % -
Revenue 3 Year -54.33 % -13.44 % -15.89 %
Revenue 5 Year - 119.18 % -
Revenue 10 Year - 429.43 % -
EBIT Growth -409.44 % 13.17 % -131.37 %
Net Income Growth -0.07 % 11.61 % -224.78 %
Net Income 3 Yeari Growth Per Share 84.07 % -46.47 % -148.34 %
Net Income 5 Yeari Growth Per Share -390.25 % 111.07 % 25.82 %
Net Income 10 Yeari Growth Per Share -390.25 % 1232.49 % -35.51 %
Operating Income Growth -15.52 % -8.23 % -133.02 %
Operating Cash Flow Growth (CFG) 11.97 % -3.78 % -143.33 %
Operating 3 Year CFG 89.94 % -38.85 % -170.73 %
Operating 5 Year CFG -6931.69 % 84.11 % 54.81 %
Operating 10 Year CFG -6931.69 % 517.51 % 40.15 %
EPS Growth 53.03 % 10.39 % -214.81 %
EPS Diluted Growth 53.03 % 10.27 % -208.93 %
Book Value Per Share -94.92 % 11.76 % -22.82 %
Share Holder 3 Year Equity Growth Per Share -89.45 % 53.21 % 1.82 %
Share Holder 5 Year Equity Growth Per Share 5501.98 % 167.88 % -24.45 %
Share Holder 10 Year Equity Growth Per Share 5501.98 % 1113.59 % -71.86 %
Dividend Per Share Growth - - -
Dividend 3 Year Growth Per Share - - -
Dividend 5 Year Growth Per Share - - -
Dividend 10 Year Growth Per Share - - -
Debt Growth -23.09 % 0.06 % 139.05 %
Free Cash Flow Growth 19.2 % -0.08 % -144.48 %
Updated On 31 Dec 2024 31 Dec 2024 31 Dec 2024
Profitability
CDIO VRTX REGN VRNA ARGX ALNY
Gross Profit Margin TTM -356.98 % 86.28 % 85.39 % 95.15 % 65.82 % 83.99 %
Return on Assets TTM -60.12 % 14.78 % 11.4 % -11.01 % 15.06 % 0.9 %
Return on Equity TTM -72.79 % 19.62 % 15.31 % -30.05 % 18.96 % 26.13 %
Return on Capital Employed TTM -62.18 % 19.59 % 10.32 % -8.31 % 5.04 % 8.03 %
Net Income Per EBT TTM 100 % 82.61 % 88.98 % 111.64 % 237.3 % -136.38 %
EBT Per Ebit TTM 100.25 % 111.4 % 139.5 % 130.36 % 147.38 % -12.07 %
EBIT Per Revenue TTM -31960.98 % 34.06 % 25.89 % -25.86 % 13.47 % 8.25 %
Cash Flow To Debt Ratio TTM -1010.41 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Receivables Turnover TTM 1.51 6.02 2.51 1.93 1.91 3.33
Payables Turnover TTM 7.1 0.4 2.3 2.37 0.9 4.37
Inventory Turnover TTM - 0.99 0.64 0.94 2.26 6.82
Fixed Asset Turnover TTM 2.01 % 388.59 % 284.82 % 6536.22 % 5009.77 % 463.12 %
Asset Turnover TTM 0.19 % 47.15 % 35.47 % 29.27 % 31.97 % 66.16 %
Operating Cash Flow Per Share TTM -3.17 14.55 48.94 -0.85 5.67 2.02
Free Cash Flow Per Share TTM -3.27 13.06 40.09 -0.85 5.58 1.68
Cash Per Share TTM 458.1 % 2459.7 % 8148.65 % 511.43 % 5536.58 % 2072.79 %
Operating Cash Flow Sales Ratio TTM -28303.79 % 31.71 % 35.59 % -43.23 % 17.54 % 8.28 %
Free Cash Flow Operating Cash Flow Ratio TTM 102.86 % 89.76 % 81.92 % 100.75 % 98.47 % 83.26 %
Cash Flow Coverage Ratios TTM -1010.41 % 202.64 % 187.43 % -29.66 % 932.29 % 9.59 %
Price To Free Cash Flows Ratio TTM -1.23 34.57 18.64 -995.27 133.11 233.46
Price To Operating Cash Flows Ratio TTM -1.21 30.9 15.32 -126.33 152.03 193.4
Price Cash Flow Ratio TTM -1.21 30.9 15.32 -126.33 152.03 193.4
Income Statement (TTM)
CDIO VRTX REGN VRNA ARGX ALNY
Revenue $0B $11.02B $14.2B $0.03B $2.19B $2.25B
Gross Profit $0B $9.49B $12.23B $0.03B $1.96B $1.92B
Gross Profit Ratio 100% 86.11% 86.13% 93.89% 89.62% 85.62%
EBITDA $-0.01B $0.49B $5.32B $-0.12B $0.11B $-0.18B
Net Income $-0.01B $-0.54B $4.41B $-0.14B $0.83B $-0.28B
EPS Diluted -9.3 -2.08 38.34 -1.73 12.78 -2.18
Balance Sheet (MRQ)
CDIO VRTX REGN VRNA ARGX ALNY
Long Term Debt $0B $1.66B $2.7B $0.12B $0.03B $2.59B
Total Liabilities $0B $6.12B $8.41B $0.27B $0.7B $4.17B
Total Equity $0.01B $16.41B $29.35B $0.2B $5.5B $0.07B
Total Investments $0B $6.65B $15.42B $0.02B $1.93B $1.73B
Total Debt $0B $1.75B $2.7B $0.12B $0.04B $2.74B
Total Assets $0.01B $22.53B $37.76B $0.47B $6.2B $4.24B
Cash Flow Statement (TTM)
CDIO VRTX REGN VRNA ARGX ALNY
Net Income $-0.01B $-0.54B $4.41B $-0.17B $0.83B $-0.28B
Inventory $0B $-0.52B $-0.62B $-0.01B $-0.1B $0.01B
Dividends Paid $0B $0B $0B $0B $0B $0B
Operating Cash Flow $-0B $-0.49B $4.42B $-0.12B $-0.08B $-0.01B
Capital Expenditure $-0B $-0.3B $-0.76B $-0B $-0.07B $-0.03B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 2.05
AAPG 28.57
AARD Aardvark Therapeutics, Inc. Common Stock 13.71
ABCL AbCellera Biologics Inc. 3.53
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 4.915
ABIO ARCA biopharma, Inc. 28.8
ABOS Acumen Pharmaceuticals, Inc. 2.11
ABPWW 0.016
ABSI Absci Corporation 3.415
ABUS Arbutus Biopharma Corporation 4.55
ABVC ABVC BioPharma, Inc. 2.05
ABVX Abivax SA American Depositary Shares 113.54
ACAD ACADIA Pharmaceuticals Inc. 26.6
ACER Acer Therapeutics Inc. 0.6601
ACET Adicet Bio, Inc. 0.4766
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 1.48
ACHV Achieve Life Sciences, Inc. 4.345
ACIU AC Immune SA 2.95
ETFs With Exposure to cdio
Ticker ETF Name Weight Percentage Price
VXF Vanguard Extended Market Index Fund 0.0001 210.625
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0.0001 158.72
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0.0001 158.74
VEMPX Vanguard Extended Market Index InstlPlus 0.0001 391.71
Unlock